SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : UPCA - Uniprime Capital Acceptance, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Janice Shell who wrote (586)8/24/1999 12:09:00 AM
From: EL KABONG!!!  Read Replies (1) | Respond to of 640
 
lvrj.com

Saturday, August 21, 1999
Copyright © Las Vegas Review-Journal

Auto dealer's stock frozen after it claims credit for AIDS cure

By John G. Edwards
Review-Journal


The ex-con who promised a treatment for AIDS is in a North Las Vegas jail, and the public company with whom he was associated was barred from further sale of stock Friday.

Secretary of State Dean Heller said his securities division took action against Uniprime Capital Acceptance because of claims about the company's alleged AIDS treatment. The stock was going through "wild volume and trading swings," according to the state official.

"The viability of the stock market is based on full and fair disclosure so that investors may make informed decisions," Heller said in a written statement.

"At this point, there is insufficient reliable information available to investors to allow them to make informed investment decisions relating to the (stock) of Uniprime," he added.

Uniprime is an automobile dealer, but it said its Plasma Plus was a discovery that could treat patients for HIV, the virus that causes AIDS.

The company said the treatment has reversed the virus in five AIDS patients in Spain.

The securities division said the company's stock shot up to $7.94 a share from $1 based on announcements the company made. Uniprime stock trades on the Nasdaq Bulletin Board under the symbol UPCA.

The Securities and Exchange Commission on July 22 suspended trading in Uniprime for 10 days because of the volatile price swings and volume changes.

The division and postal inspectors used a search warrant and examined the contents of the Uniprime office in Las Vegas on Aug. 12. Postal Inspectors in New York didn't respond to a request for information about their investigation.

On the same day, Albert J. Flores, 45, who allegedly developed the AIDS treatment called Plasma Plus, was arrested. He is wanted for fraud by check and criminal contempt in Delta, Colo. He served time in a Colorado prison between 1983 and 1992 for participation in a criminal conspiracy.

The securities division Friday served Uniprime with an order eliminating any exemption the company might claim to requirements for selling stock in Nevada. That order prohibits anyone from selling Uniprime stock in Nevada until the stock is registered with the securities division.

The Nevada securities division complaint names Uniprime and Gary Tabb, president of the company.

The securities division in December obtained the company's agreement to comply with state securities laws. The division said Tabb had hired eight unlicensed brokers to sell Uniprime stock and hadn't registered securities for sale in the state.


KJC



To: Janice Shell who wrote (586)8/24/1999 4:25:00 AM
From: EL KABONG!!!  Read Replies (1) | Respond to of 640
 
sos.state.nv.us

Dean Heller
Nevada Secretary of State

PRESS RELEASES
August 20, 1999

EX-CON ARRESTED DURING SECURITIES INVESTIGATION


Las Vegas, NV - Today, the Nevada Secretary of State, Securities Division, issued a Summary Order revoking all exemptions from registration for the securities of Uniprime Capital Acceptance, Inc. The securities traded on the Bulletin Board under the symbol 'UPCA'.

Secretary of State, Dean Heller stated, "The viability of the stock market is based on full and fair disclosure so that investors may make informed decisions. At this point there is insufficient reliable information available to investors to allow them to make an informed investment decision relating to the securities of Uniprime."

Uniprime has been the center of a recent controversy relating to a treatment called Plasma Plus which allegedly reversed the HIV virus in five AIDS patients in Spain. Based on the announcements issued by Uniprime, the stock price shot up from under $1.00 to approximately $7.94 per share. Because of the wild volume and trading swings, the stock was suspended from trading by the Securities Exchange Commission on July 22 for ten days.

On August 12, 1999 the Division participated in the execution of a search warrant on Uniprime with Postal Inspectors from Las Vegas and New York. On the same day Albert Flores, the alleged developer of Plasma Plus, was arrested by the Postal Inspectors. Mr. Flores has an extensive criminal history which includes serving time at a Colorado State Facility from 1983 - 1992. He is also wanted on two warrants from Colorado. The Securities Division contacted the appropriate authorities from Colorado to let them know that Mr. Flores is in custody.

Based on the trading of the stock, news releases by the company, failure of the company to claim what exemption from registration it was using to sell stock from Nevada, and other problems associated with the company, the Division issued the Order which prohibits anyone from selling Uniprime stock in Nevada until the stock is registered with the Securities Division.

The Secretary of State, Securities Division regulates the offer and sale of securities in Nevada. Information for investors can be found on the web site under investor education at sos.state.nv.us or by calling 1-800-758-6440. For information on the licensing status of your investment professional call 1-800-758-6440.

Copyright © 1996-1999


KJC